Geoffrey M. Parker

Insider Reports History

Entity
Individual
Location
15 Riordan Place, Menlo Park, California
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geoffrey M. Parker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 1,164,418 $3.38 M $2.90 May 16, 2024 Direct
PERRIGO Co plc Director Ordinary Shares 20,262 $612 K $30.22 May 15, 2024 Direct
Better Therapeutics, Inc. Director Common Stock 1,031,805 $175 K $0.17 Dec 18, 2023 Direct
Better Therapeutics, Inc. Director Common Stock 53,333 $9.06 K $0.17 Dec 18, 2023 By Parker Trust
Tricida, Inc. COO, CFO and EVP Employee Stock Option (right to buy) 256,000 Feb 28, 2022 Direct
Allogene Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to buy) 103,939 Jan 25, 2024 Direct
ChemoCentryx, Inc. Director Common Stock 0 $50.95 Oct 20, 2022 By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA
ChemoCentryx, Inc. Director Common Stock 0 $50.95 Oct 20, 2022 Direct
ChemoCentryx, Inc. Director Common Stock 0 $50.95 Oct 20, 2022 Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust
ChemoCentryx, Inc. Director Restricted Stock Unit 0 Oct 20, 2022 Direct
ChemoCentryx, Inc. Director Stock Option 0 Oct 20, 2022 Direct
PERRIGO Co plc Director Restricted Stock Units 0 May 15, 2024 Direct

Insider Reports Filed by Geoffrey M. Parker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. May 16, 2024 1 1,000,001 4 May 20, 2024 CHIEF FINANCIAL OFFICER
PRGO PERRIGO Co plc May 14, 2024 4 137,713 4 May 16, 2024 Director
ALLO Allogene Therapeutics, Inc. Jan 30, 2024 1 683 4 Mar 6, 2024 CHIEF FINANCIAL OFFICER
ALLO Allogene Therapeutics, Inc. Jan 25, 2024 2 0 4 Jan 31, 2024 CHIEF FINANCIAL OFFICER
BTTX Better Therapeutics, Inc. Dec 18, 2023 1 0 4 Dec 20, 2023 Director
ALLO Allogene Therapeutics, Inc. Oct 16, 2023 3 0 4 Oct 17, 2023 CHIEF FINANCIAL OFFICER
ALLO Allogene Therapeutics, Inc. Oct 16, 2023 0 0 3 Oct 16, 2023 CHIEF FINANCIAL OFFICER
BTTX Better Therapeutics, Inc. Jul 27, 2023 1 500,000 4 Jul 31, 2023 Director
PRGO PERRIGO Co plc Jun 13, 2023 1 330,637 4 Jun 14, 2023 Director
BTTX Better Therapeutics, Inc. Jun 7, 2023 1 0 4 Jun 9, 2023 Director
PRGO PERRIGO Co plc May 17, 2023 3 132,886 4 May 19, 2023 Director
PRGO PERRIGO Co plc May 15, 2023 1 0 4 May 17, 2023 Director
BTTX Better Therapeutics, Inc. Apr 10, 2023 1 250,000 4 Apr 12, 2023 Director
PRGO PERRIGO Co plc Mar 6, 2023 1 190,270 4 Mar 7, 2023 Director
CCXI ChemoCentryx, Inc. Oct 20, 2022 9 0 4 Oct 24, 2022 Director
BTTX Better Therapeutics, Inc. Jun 13, 2022 1 36,183 4 Jun 14, 2022 Director
BTTX Better Therapeutics, Inc. Jun 9, 2022 1 0 4 Jun 10, 2022 Director
CCXI ChemoCentryx, Inc. May 26, 2022 2 0 4 May 31, 2022 Director
CCXI ChemoCentryx, Inc. May 20, 2022 2 0 4 May 24, 2022 Director
PRGO PERRIGO Co plc May 17, 2022 4 132,334 4 May 19, 2022 Director
CCXI ChemoCentryx, Inc. May 2, 2022 2 180,250 4 May 3, 2022 Director
BTTX Better Therapeutics, Inc. Mar 29, 2022 1 32,231 4 Mar 31, 2022 Director
TCDA Tricida, Inc. Feb 28, 2022 1 0 4 Mar 2, 2022 COO, CFO and EVP
TCDA Tricida, Inc. Dec 31, 2021 1 -13,231 4 Jan 4, 2022 COO, CFO and EVP
PRGO PERRIGO Co plc Dec 16, 2021 1 184,270 4 Dec 17, 2021 Director
BTTX Better Therapeutics, Inc. Dec 14, 2021 1 98,800 4 Dec 16, 2021 Director
TCDA Tricida, Inc. Nov 15, 2021 2 1,000,002 4 Nov 17, 2021 COO, CFO and EVP
BTTX Better Therapeutics, Inc. Oct 28, 2021 2 0 4 Nov 1, 2021 Director
BTTX Better Therapeutics, Inc. Oct 28, 2021 0 0 3 Nov 1, 2021 Director
PRGO PERRIGO Co plc May 17, 2021 1 0 4 May 19, 2021 Director
PRGO PERRIGO Co plc May 7, 2021 3 129,653 4 May 11, 2021 Director
CCXI ChemoCentryx, Inc. Mar 10, 2021 5 0 4 May 24, 2021 Director